AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Zoladex (goserelin) — Worldwide product sales by Year
Zoladex (goserelin) — Worldwide product sales ($M) ($M)
AstraZeneca Zoladex (goserelin) — Worldwide product sales: $1,106M in FY2025, up 4.5% from a year earlier. That is the highest of the 10 years on record here.
Where the FY2025 figure comes from
“|| Zoladex | 1,106 | 5 | 6 | 19 | 17 | 842 | 6 | 8 | 157 | 6 | 3 | 88 | (11) | (10)”
Source: Form 6-K FY2025Q4 Earnings Release ↗
Reported in Form 6-K Quarterly & Form 20-F Product Sales by Medicine & Region Tables.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Zoladex (goserelin) — Worldwide product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,106 | +4.5% | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 1,058 | +11.1% | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2023 | Dec 31, 2023 | 952 | +2.7% | Form 6-K FY2023Q4 Earnings Release ↗ |
| FY2022 | Dec 31, 2022 | 927 | -2.2% | Form 6-K FY2022Q4 Earnings Release ↗ |
| FY2021 | Dec 31, 2021 | 948 | +6.8% | Form 6-K FY2021Q4 Earnings Release ↗ |
| FY2020 | Dec 31, 2020 | 888 | +9.2% | Form 6-K FY2020Q4 Earnings Release ↗ |
| FY2019 | Dec 31, 2019 | 813 | +8.1% | Form 20-F (filed 2020-03-03) ↗ |
| FY2018 | Dec 31, 2018 | 752 | +2.3% | Form 20-F (filed 2019-03-05) ↗ |
| FY2017 | Dec 31, 2017 | 735 | -9.9% | Form 20-F (filed 2019-03-05) ↗ |
| FY2016 | Dec 31, 2016 | 816 | – | Form 20-F (filed 2019-03-05) ↗ |
Breakdown
What makes up zoladex (goserelin) — Worldwide product sales
- Zoladex (goserelin) — Worldwide YoY actual (%)5.0% · FY2025
- Zoladex (goserelin) — Worldwide YoY CER (%)6.0% · FY2025
- Zoladex (goserelin) — US product sales ($M)19 · FY2025
- Zoladex (goserelin) — Emerging Markets product sales ($M)842 · FY2025
- Zoladex (goserelin) — Europe product sales ($M)157 · FY2025
- Zoladex (goserelin) — Established RoW product sales ($M)88 · FY2025
Cite this data
StockData. (2026). AstraZeneca Zoladex (goserelin) — Worldwide product sales ($M), annual FY2016–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-zoladex-world
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.